Yahoo Poland Wyszukiwanie w Internecie

Search results

1. covid19criticalcare.com › protocol › i-recI-RECOVER: Long COVID Treatment - FLCCC Alliance

   covid19criticalcare.com › protocol › i-rec

   • Zapisane w pamięci cache

   I-RECOVER is the Long COVID treatment protocol by the FLCCC alliance. Long COVID is a prolonged illness that occurs after a COVID infection.

   • Nutritional Therapeutics and Covid-19

     Nutritional Therapeutics and COVID-19 Also read From A to...

   • Vitamins and Nutraceuticals During Pregnancy

     This page features a list of vitamins and nutraceuticals...

   • Flccc

     This is a translation of FLCCC Protocols into Spanish...

   • Frequently Asked Questions

     Here is a page dedicated to the many frequently asked...

   • I-prevent

     I-PREVENT is the vaccine injury prevention protocol...

   • I-recover

     I-RECOVER Post-Vaccine Treatment Guide Download I-RECOVER...

2. jamanetwork.com › journals › jamaEffect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to...

   jamanetwork.com › journals › jama

   Among outpatients with mild or moderate COVID-19, treatment with ivermectin, with a targeted maximum dose of 600 μg/kg daily for 6 days, was not shown to improve time to sustained recovery compared with placebo. These findings do not support the use of ivermectin in outpatients with COVID-19.

3. www.nejm.org › doi › fullEffect of Early Treatment with Ivermectin among Patients with...

   www.nejm.org › doi › full

   30 mar 2022 · The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the...

4. www.nejm.org › doi › fullIvermectin Treatment for Covid-19 | NEJM - New England Journal of...

   www.nejm.org › doi › full

   14 gru 2022 · Given the wide availability and low cost of ivermectin and that the dosage used in the trial appeared to be safe, such treatment effects could be an important benefit for high-risk patients who do...

5. www.thelancet.com › journals › laninfOutpatient treatment of COVID-19 and incidence of post-COVID-19...

   www.thelancet.com › journals › laninf

   8 cze 2023 · We aimed to evaluate whether outpatient COVID-19 treatment with metformin, ivermectin, or fluvoxamine soon after SARS-CoV-2 infection could reduce the risk of long COVID.

6. www.sciencedirect.com › science › articleEfficacy and safety of ivermectin for treatment of...

   www.sciencedirect.com › science › article

   1 sie 2024 · The effects of ivermectin for treating COVID-19 in outpatient settings with asymptomatic or mild disease was evaluated in six RCTs for all-cause mortality (n = 2,860) and in two RCTs for worsening of clinical status (hospitalization or death within 28 days). Authors concluded that ivermectin probably had little or no effect on these outcomes ...

7. pubmed.ncbi.nlm.nih.gov › 34375047Review of the Emerging Evidence Demonstrating the Efficacy of ...

   pubmed.ncbi.nlm.nih.gov › 34375047

   22 kwi 2021 · Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.